• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.

作者信息

Strathdee S A, Frank J W, McLaughlin J, Leblanc M, Major C, O'Shaughnessy M V, Read S E

机构信息

British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.

出版信息

J Infect Dis. 1995 Nov;172(5):1375-9. doi: 10.1093/infdis/172.5.1375.

DOI:10.1093/infdis/172.5.1375
PMID:7594682
Abstract

Studies examining specific antibodies directed against antigenic components of human immunodeficiency virus (HIV), as potential markers of progression to AIDS, have reported inconsistent results. We used reflectance densitometry and survival analysis to determine whether single quantitative measures of HIV-specific antibodies predicted progression to AIDS in a prospective cohort of 159 HIV-infected homosexual men. Lowered baseline levels of p24 antibody and p24/gp41 antibody ratio were independent predictors of progression to AIDS and retained statistical significance after simultaneously controlling for CD4:CD8 ratio, age, use of zidovudine, and clinical symptoms. Quantitative measures of p24 antibody and p24/gp41 antibody ratio warrant further study with regards to their clinical application as markers of HIV disease progression.

摘要

相似文献

1
Quantitative measures of human immunodeficiency virus-specific antibodies predict progression to AIDS.
J Infect Dis. 1995 Nov;172(5):1375-9. doi: 10.1093/infdis/172.5.1375.
2
Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.CD4+细胞计数<200×10⁶/L但无艾滋病定义临床疾病的HIV感染同性恋男性疾病进展的预测因素。
AIDS. 1994 Nov;8(11):1577-83. doi: 10.1097/00002030-199411000-00009.
3
Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.HIV-1感染后针对gp41、p24和p17的IgG抗体亲和力的差异成熟
Clin Exp Immunol. 1996 Feb;103(2):185-91. doi: 10.1046/j.1365-2249.1996.951642.x.
4
Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia.循环CD4 + T淋巴细胞和p24抗原血症与患有口腔毛状白斑的HIV感染受试者发生艾滋病风险的关系。
J Oral Pathol Med. 1996 Mar;25(3):108-11. doi: 10.1111/j.1600-0714.1996.tb00203.x.
5
Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.进展为获得性免疫缺陷综合征的免疫标志物具有时间依赖性和疾病特异性。
Am J Epidemiol. 1992 Jul 1;136(1):71-80. doi: 10.1093/oxfordjournals.aje.a116422.
6
The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam.
J Infect Dis. 1995 Jul;172(1):97-104. doi: 10.1093/infdis/172.1.97.
7
Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels.人类免疫缺陷病毒1型(HIV-1)感染非进展和缓慢进展的预测因素:血清中低病毒RNA拷贝数以及维持高HIV-1 p24特异性而非V3特异性抗体水平。
J Infect Dis. 1995 Apr;171(4):811-21. doi: 10.1093/infdis/171.4.811.
8
[Titer of anti-P24 and anti-GP41 antibodies as a diagnostic parameter in patients with asymptomatic and symptomatic HIV infections].[抗P24和抗GP41抗体滴度作为无症状和有症状HIV感染患者的诊断参数]
Pol Arch Med Wewn. 1991 Dec;86(6):355-9.
9
Appearance of predictors of disease progression in relation to the development of AIDS.与艾滋病发展相关的疾病进展预测指标的出现情况。
AIDS. 1989 Sep;3(9):563-9. doi: 10.1097/00002030-198909000-00002.
10
Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.艾滋病进展的免疫标志物:五个艾滋病毒感染队列的一致性。多队列分析项目研讨会。第一部分。
AIDS. 1994 Jul;8(7):911-21.

引用本文的文献

1
Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo.将HIV Gagp24递送至DCIR可在体内诱导强烈的抗体反应。
PLoS One. 2015 Sep 25;10(9):e0135513. doi: 10.1371/journal.pone.0135513. eCollection 2015.
2
The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.感染人类免疫缺陷病毒(HIV)且患有口腔毛状白斑、卡波西肉瘤和非霍奇金淋巴瘤患者的癌症相关病毒图谱
AIDS Res Treat. 2012;2012:634523. doi: 10.1155/2012/634523. Epub 2012 Aug 8.
3
T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus.
T 细胞非依赖的针对猴免疫缺陷病毒包膜蛋白的次级抗体应答。
Retrovirology. 2012 May 14;9:42. doi: 10.1186/1742-4690-9-42.
4
The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection.用于研究在自然感染过程中产生的人类HIV特异性抗体反应的脾内人外周血淋巴细胞-非肥胖糖尿病/严重联合免疫缺陷(huPBL NOD/SCID)模型。
J Immunol Methods. 2007 Mar 30;320(1-2):49-57. doi: 10.1016/j.jim.2006.12.003. Epub 2007 Jan 9.
5
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections.针对猿猴免疫缺陷病毒、猿猴-人类免疫缺陷病毒及1型人类免疫缺陷病毒感染的抗体成熟共同主题。
J Virol. 1998 Oct;72(10):7852-9. doi: 10.1128/JVI.72.10.7852-7859.1998.
6
Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.对用减毒活猿猴免疫缺陷病毒疫苗免疫的恒河猴的病毒复制、免疫反应及效力进行的时间分析。
J Virol. 1998 Sep;72(9):7501-9. doi: 10.1128/JVI.72.9.7501-7509.1998.
7
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.HIV-1抗原特异性和非特异性B细胞反应对抗逆转录病毒联合疗法敏感。
J Exp Med. 1998 Jul 20;188(2):233-45. doi: 10.1084/jem.188.2.233.
8
Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS.人类免疫缺陷病毒1型准种在进展至艾滋病过程中的进化减缓。
J Virol. 1997 Oct;71(10):7498-508. doi: 10.1128/JVI.71.10.7498-7508.1997.
9
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.1型人类免疫缺陷病毒Gag和Env蛋白抗体应答的差异调节
J Virol. 1997 Apr;71(4):2799-809. doi: 10.1128/JVI.71.4.2799-2809.1997.